La Journée Zéro Émission est une initiative mondiale de sensibilisation à l’impact des activités humaines sur le changement climatique, qui vise également à promouvoir des pratiques durables. 

September is a month dedicated to raising awareness about Primary Biliary Cholangitis, I find myself reflecting on the challenges faced by those living with rare cholestatic disease. PBC Awareness Day on September 10th is not just a date on the calendar; it’s a reminder that understanding and suppor

At Ipsen, our commitment to supporting para-athletes is a direct reflection of our core values. We believe in removing barriers and fostering an environment where diversity is celebrated, and every individual is supported to drive innovation. Our company culture encourages all employees to reach the

It was only at 46 years old that Stephen was diagnosed with neuroendocrine cancer. Lovingly married to his wife and father to two sons freshly out of high school, in the prime of life with decades ahead of him, Stephen was shocked and confused by his diagnosis. His doctor told him he had 10 to 15 ye

“We’re often asked, what is the PBC journey? And the challenge is that, well, the PBC journey doesn’t exist. There are thousands and thousands of patients around the world, and each of them have an individual journey.” 

Chez Ipsen, notre stratégie repose sur un principe clé, celui de prendre des risques calculés pour stimuler l’innovation.

At Ipsen, our commitment to supporting para-athletes is deeply aligned with our core values of cultivating and embracing diversity. By standing alongside these incredible athletes, we demonstrate our dedication to fostering an inclusive environment where every individual is valued and encouraged to

Le Groupe a enregistré, pour les six premiers mois de l’exercice 2024, une forte croissance des ventes de 9,5 % à taux de change constant, avec une marge opérationnelle des activités de 32,4 %. À la lumière de ces excellents résultats, nous avons revu à la hausse nos objectifs financiers pour l’exer

Lors du congrès de l’Association européenne pour l’étude du foie (European Association for the Study of the Liver, EASL), d’éminents spécialistes en hépatologie, Dr Mark Swain, Dr Emma Culver et Dr Marco Carbone ont échangé sur l’efficacité de la prise en charge de la cholangite biliaire primitive (

Les résultats financiers du premier semestre seront publiés le 25 juillet 2024 à 7H00 et une conférence téléphonique aura lieu à 13H00 CET.